BeOne Medicines Ltd.
ONCBeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment. Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
Drugs in Pipeline
7
Phase 3 Programs
6
Upcoming Catalysts
1
Next Catalyst
Nov 2026
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
How ONC's past catalysts played out
Pirtobrutinib
Chronic Lymphocytic Leukemia
BGB-16673
B-cell Malignancy
Subcutaneous Tislelizumab
Metastatic Gastric Adenocarcinoma
BGB-43395
HR+/HER2- Breast Cancer
Sonrotoclax
Mantle Cell Lymphoma
Tislelizumab
Advanced Malignancies
Zanubrutinib
Chronic Lymphocytic Leukemia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Pirtobrutinib | Phase 3 | Chronic Lymphocytic Leukemia | - | - |
BGB-16673 | Phase 3 | B-cell Malignancy | - | - |
Subcutaneous Tislelizumab | Phase 3 | Metastatic Gastric Adenocarcinoma | - | - |
BGB-43395 | Phase 3 | HR+/HER2- Breast Cancer | - | - |
Sonrotoclax | Phase 3 | Mantle Cell Lymphoma | - | - |
Tislelizumab | Phase 3 | Advanced Malignancies | - | - |
Zanubrutinib | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in BeOne Medicines Ltd.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in BeOne Medicines Ltd.'s (ONC) pipeline across Phase 3, Phase 2. Its lead program is Pirtobrutinib (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is BeOne Medicines Ltd.'s next FDA catalyst?→
BeOne Medicines Ltd.'s (ONC) next tracked catalyst is a Phase 2 expected November 15, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ONC biotech catalysts?→
Add ONC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BeOne Medicines Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.